Blog: What the Autism Spectrum Wheel Can and Cannot Show
The autism spectrum wheel offers a more accurate picture than placing autistic people on a single line from mild to severe. It can display differences in communication, sensory experience, flexibility, relationships, daily function, strengths, and…
Blog: What Cannabinoid Safety for Autistic Children Requires
Cannabinoid safety for autistic children requires more precision than broad claims about cannabis and autism. Randomized trials of purified CBD and CBD-dominant formulations have produced mixed results, including negative primary outcomes alongside…
CBD for Severe Autism: What a 27-Month Study Found
A new long-term observational study published in Pharmacology Biochemistry and Behavior followed children with severe autism spectrum disorder on purified CBD for an average of 27.6 months. Improvements seen at three months were maintained, and 40% of…
Cannabis Derivatives & Autism Spectrum Disorder: Evidence from Clinical Research
Cannabis derivatives autism spectrum disorder evidence shows early promise for managing symptoms like anxiety and behavioral challenges. However, current clinical research remains limited and inconclusive. More rigorous trials are needed to establish…
What Pediatric Autism Cannabinoid Studies Actually Show
Cannabinoids for autism behavior are increasingly discussed by families seeking help for irritability, aggression, sleep, anxiety, and daily functioning. This review finds a limited but clinically relevant signal for selected outcomes, especially with…
Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support.
A rigorous clinical trial found that CBD autism spectrum disorder clinical trial results showed measurable brain activity changes in children with high-support autism. While promising for understanding CBD's neurological effects, the study did not…
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.
A large Israeli healthcare study examining medical cannabis prescribing patterns autism children found only 1.2% of autistic individuals received prescriptions, but concerning pediatric use patterns suggest need for stricter clinical oversight and…
Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness.
A comprehensive systematic review examining cannabinoids for autism in children and adolescents reveals promising response rates of 49% versus 21% placebo, though evidence quality limitations require careful clinical interpretation. The review…
Endocannabinoid System in Autism Development Research
Maternal cannabis exposure autism risk is linked to behavioral problems and developmental delays in children. Research shows stronger associations in children with autism spectrum disorder symptoms. Understanding these risks is crucial for clinical…
Research on Maternal Cannabis Exposure and Offspring Neurodevelopment
Maternal cannabis exposure risk ASD ADHD offspring is linked to modest increases in autism spectrum disorder and ADHD risks. Research highlights potential effects on fetal brain development via cannabinoid receptors. These findings emphasize the…